Post job

Genencor International main competitors are Illumina, PacBio, and Regeneron.

Competitor Summary. See how Genencor International compares to its main competitors:

  • Regeneron has the most employees (9,123).
  • Employees at Illumina earn more than most of the competitors, with an average yearly salary of $94,044.
Work at Genencor International?
Share your experience

Genencor International vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
1982
4.4
Palo Alto, CA1$380.0M1,500
Elitra Pharmaceuticals
-
4.1
San Diego, CA1$2.2M5
indimolecular
2013
3.6
Culver City, CA1$590,00012
1988
4.9
Tarrytown, NY7$14.2B9,123
1978
4.7
Madison, WI2$450.0M1,601
1997
4.7
Bothell, WA3$2.0B900
1987
4.7
Gaithersburg, MD1$422.2M6,030
2010
4.8
Cambridge, MA2$3.2B2,500
1967
4.2
Northwood, OH5$13.0M142
1995
4.7
Austin, TX3$417.4M1,140
1992
3.3
Richmond, VA1$1.1M29
2006
4.1
Lexington, MA2$7.2M182
1950
4.1
Malvern, PA1$94.8M7,500
Morphotek
2000
3.7
Exton, PA1$4.8M1
1984
4.8
Bridgewater, NJ1$39.0M180
Opexa Therapeutics
1986
3.9
The Woodlands, TX3$2.9M23
1998
4.8
San Diego, CA5$4.4B7,800
1992
4.9
Rockville, MD1$131.0M1,000
1998
4.4
Alameda, CA1-750
1995
4.5
Hopkinton, MA1$109.8M200
2004
4.7
Menlo Park, CA1$154.0M400

Rate Genencor International's competitiveness in the market.

Zippia waving zebra

Genencor International salaries vs competitors

Among Genencor International competitors, employees at Illumina earn the most with an average yearly salary of $94,044.

Compare Genencor International salaries vs competitors

CompanyAverage salaryHourly salarySalary score
Genencor International
$70,618$33.95-
Elitra Pharmaceuticals
$45,902$22.07-
indimolecular
$45,020$21.64-
Regeneron
$85,589$41.15-
Promega
$72,593$34.90-
Seagen
$85,008$40.87-

Compare Genencor International job title salaries vs competitors

CompanyHighest salaryHourly salary
Genencor International
$93,565$44.98
Regeneron
$106,313$51.11
Illumina
$101,046$48.58
Promega
$100,942$48.53
Medimmune
$99,246$47.71
Namsa
$98,075$47.15
AIBioTech
$97,453$46.85
T2 Biosystems
$97,274$46.77
Opexa Therapeutics
$95,556$45.94
Luminex
$94,649$45.50
Moderna
$92,844$44.64
Morphotek
$89,039$42.81
Fujirebio Europe
$87,825$42.22
Celera
$85,375$41.05
Caliper Life Sciences
$85,246$40.98
Human Genome Sciences
$85,204$40.96
Seagen
$84,219$40.49
ImClone Systems LLC
$82,551$39.69
Elitra Pharmaceuticals
$80,188$38.55
indimolecular
$79,766$38.35

Do you work at Genencor International?

Is Genencor International able to compete effectively with similar companies?

Genencor International jobs

Genencor International demographics vs competitors

Compare gender at Genencor International vs competitors

Job titleMaleFemale
Medimmune53%47%
Regeneron54%46%
Luminex59%41%
Illumina62%38%
PacBio65%35%
Genencor International--

Compare race at Genencor International vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
46%23%7%20%5%
9.7
48%23%11%14%3%
9.8
42%20%5%27%5%
9.6
54%15%10%17%4%
9.8
48%12%17%18%5%
9.9
56%13%8%21%3%
9.0

Genencor International and similar companies CEOs

CEOBio
Francis A. Desouza
Illumina

Francis Aurelio deSouza (born December 2, 1970) is an American entrepreneur and business executive. He is the president and chief executive officer (CEO) of Illumina and a member of the Board of Directors of The Walt Disney Company.

Nachum Shamir
Luminex

With a proven track record of bringing game-changing technologies to the market, Mr. Shamir joined Luminex Corporation as President, Chief Executive Officer, and Board Member in 2014. From 2006 to 2014, Mr. Shamir served as President and CEO of Given Imaging, a developer, manufacturer, and marketer of diagnostic products for the visualization and detection of disorders of the gastrointestinal tract, which was acquired by Covidien PLC in early 2014. Mr. Shamir currently serves on the board of directors of Exalenz Bioscience Ltd. (TASE: EXEN). He has previously served as a Board Member at Scitex Corporation, Cogentix Medical (NASDAQ: CGNT), recently acquired by Laborie Medical Technologies, and invendo medical GmBH, now part of Ambu. Mr. Shamir holds a Bachelor of Science from the Hebrew University of Jerusalem and a Masters of Public Administration from Harvard University.

David McWilliams
Opexa Therapeutics

Christian O. Henry
PacBio

Roger D. Dansey
Seagen

John J. Sperzel
T2 Biosystems

CEO at T2 Biosystems | Board Member | Heart Transplant Recipient | Sepsis Survivor | Best Selling Author | Inspirational Speaker

Speck Loe
Medimmune

Speck Loe works at Medimmune and a Ceo at Medimmune and is based in Granite Falls, Washington.

Christophe Berthoux
Namsa

Christophe Berthoux is an Exec VP:Global Sales & Mktg/Chief Commercial Ofcr at CHARLES RIVER LABORATORIES, Member of the Board of Directors at Synexus, and Chairman at IMAGE ANALYSIS INC and is based in London, Greater London, United Kingdom. He has worked as CEO at Synexus, Chief Executive Officer at Synexus Clinical Research Ltd, and Gen Mgr:Clinical Svcs at CHARLES RIVER LABORATORIES.

Dr Nicholas Nicolaides
Morphotek

Genencor International competitors FAQs

Search for jobs